CAR-T therapy for kidney cancer shows early signs of efficacy in Chinese trial

A Chinese company has presented early clinical data on two CAR-T therapies in patients with kidney cancer, and it plans to decide by the end of...

Biofourmis raises $35M to support AI-based digital therapeutics for chronic disease

Singaporean startup Biofourmis has raised a $35 million Series B financing round led by to support the growth and commercialization of its digital therapeutics platform and...

ElevateBio names AlloVir as its first portfolio company

The Houston-based company is developing a cell therapy for patients with compromised immune system, which it plans to move into Phase III studies within the next...

An inside look at UnityPoint Health’s new partnership with startups

Many health systems have created teams to invest in startups and commercialize their own technology, either to scale it within their own institutions or offer it...

Nashville healthcare innovation fund Jumpstart Foundry adds 15 startups to its portfolio

Jumpstart Foundry, a Nashville, Tennessee-based seed stage healthcare innovation fund, has selected 15 startups for its 2019 cohort. The companies have footholds in the ambulatory, hospital,...

Merck’s Keytruda fails in Phase III triple-negative breast cancer study, but has a few...

A clinical trial of Merck & Co.’s flagship oncology drug in a form of breast cancer has failed. However, the company is also running additional trials...

Alphabet’s Verily boosts its Project Baseline with new health system, pharma partners

Alphabet’s Verily life science division launched its Project Baseline back in 2017 with the ambition to make it easier for individuals to get involved in the...

Nightware receives breakthrough designation for its PTSD nightmare therapy technology

Oftentimes individuals suffering from post-traumatic stress disorder experience severe nightmares where they relive horrible experiences from their past over and over again. These kinds of nightmare disorders...

After Walmart, Mayo pushes further into workplace health

Rochester, Minnesota-based Mayo Clinic already has a Centers of Excellence program with Walmart, but through a new collaboration, it is making another move into the workplace health...

New antibiotics are urgently needed, but economics stand in the way

On March 10, 2017, shares of antibiotic developer Achaogen traded at $27 on the Nasdaq. Two years later, it has become a penny stock trading at around...

Must Read